Takeda Pharmaceuticals International AG has 9 disclosed EU lobbying meetings from 2024-12-10 to 2026-04-29: 4 with the European Commission and 5 with Members of the European Parliament. Source: EU Transparency Register no. 815176718826-78, Commission disclosures and MEP declarations. Methodology
Takeda Pharmaceuticals International AG
EU lobbying footprint — who they meet, and on what.
- Register no.
- 815176718826-78 ↗
- Disclosed meetings
- 9 (4 Commission · 5 MEP)
- Period
- 2024-12-10 → 2026-04-29
Declared fields of interest: Business and industry · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Environment · External relations · Foreign affairs and security policy · Humanitarian aid and civil protection · Institutional affairs · Public health
Lobbying profile
as declared 2026-04-01- Category
- Companies & groups
- Legal status
- AG
- Declared lobbying cost
- €1,000,000
- Lobbying FTEs
- 1.75
- Members
- 3
At a glance
- Health2
- Jana Dabbelt2
- Ulla Schwager1
- Patricia Reilly1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- SANT COMMITTEE ONGOING WORKsource ↗
- 2026-04-28ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiEUCOPE - Strasbourgsource ↗
- Salud públicasource ↗
- 2025-12-03ECUlla Schwager · Head of UnitExchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sectorsource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- 2025-06-25ECPatricia Reilly · Cabinet of President Ursula von der Leyenthe EU biopharmaceutical landscapesource ↗
- Priorites for the mandatesource ↗
- Industrial Policysource ↗
- European health policysource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Takeda Pharmaceuticals International AG disclosed?
Takeda Pharmaceuticals International AG (EU Transparency Register no. 815176718826-78) appears in 9 disclosed meetings with EU officials and MEPs between 2024-12-10 and 2026-04-29: 4 with the European Commission and 5 with Members of the European Parliament.
What does Takeda Pharmaceuticals International AG lobby on?
Takeda Pharmaceuticals International AG's disclosed EU meetings most often concern Health. Every meeting and its topic is listed with its official source on this page.
Who does Takeda Pharmaceuticals International AG meet in Brussels?
Across its disclosed meetings, Takeda Pharmaceuticals International AG has met Commission officials including Jana Dabbelt, Ulla Schwager, Patricia Reilly, and MEPs including DE LA PISA CARRIÓN Margarita, NEVADO DEL CAMPO Elena, HANSEN Niels Flemming. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 815176718826-78) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.